advanced search  
Updated Jun. 13, 2008
 
 
 
Drug Combo Radically Reduces Recurrent Colorectal Adenomas
ISSUE: MAY, 2008
A combination of the targeted agent difluoromethylornithine (DFMO) at a low dose and sulindac, a nonsteroidal anti-inflammatory drug, appears to reduce the risk for recurrent colorectal adenomas by up to 95% with less toxicity than chemotherapy, according to a Phase III trial. read more
In HER2-Positive Patients…Breast Cancer Vaccine May Reduce Mortality by 50%
ISSUE: MAY, 2008
Women with breast cancer that over-expresses HER2/neu appear to respond well to a new HER2 E75 peptide vaccine and have a 50% absolute reduction in mortality compared with controls, according to results from a Phase II trial by Texas researchers. Rather unexpectedly, the researchers also found that women with tumors that are low expressers of HER2 exhibited a better response to treatment, not only immunologically but also clinically, with a decreased recurrence of breast cancer and no mortality following vaccination. read more
The Cost of Extending Life
ISSUE: MAY, 2008
At the New Mexico Cancer Center in Albuquerque, a breast cancer patient recently approached Barbara L. McAneny, MD, wanting to switch from oral chemotherapy to intravenous chemotherapy. The issue wasn’t the effectiveness of capecitabine (Xeloda, Roche Laboratories)—it was the cost. read more
The Right Stuff
Evaluating Business Opportunities and Investments
ISSUE: MAY, 2008
Physicians today are increasingly involved in business and financial opportunities that include limited liability companies, partnerships, joint ventures, capital purchases, real estate and other investments. The two biggest mistakes people can make are to invest for the wrong reason and not do homework before taking the plunge. This article provides basic insight into some of the business and legal issues that a physician should keep in mind when evaluating an opportunity. read more
 
 
 
MAY, 2007
Breast Cancer Management: Targeted Therapeutics and Predictive Markers
Current Update on the Management of Gastrointestinal Stromal Tumor
Clinical Responses of Imatinib Mesylate in Chronic Myeloid Leukemia
Therapeutic Strategies for Patients With Chronic Lymphocytic Leukemia
Guide for the Administration and Use of Cancer Therapeutic Agents 2007
more  
 




•  The Book Page - May 2008

•  The Book Page - April 2008

•  Guide to Cancer Therapeutic Regimens for Solid Tumors

•  Guide to Cancer Therapeutic Regimens Hematologic Cancers

•  The Book Page - June 2008

•  Drug Combo Radically Reduces Recurrent Colorectal Adenomas

•  Guide for the Administration and Use of Cancer Therapeutic Agents 2008

•  In HER2-Positive Patients…Breast Cancer Vaccine May Reduce Mortality b

•  Myelodysplasia: Recent Advances

•  Lapatinib May Benefit Some Men With Prostate Cancer

 
EDUCATIONAL REVIEW
Guide to Cancer Therapeutic Regimens for Solid Tumors
SOLID TUMORS
Drug Combo Radically Reduces Recurrent Colorectal ...  [5/2008]
In HER2-Positive Patients…Breast Cancer Vaccine Ma...  [5/2008]
Pregnancy-Associated Breast Cancer: Study Spurs De...  [5/2008]
more 
SYMPTOM CONTROL /
PALLIATIVE CARE
Denosumab Boosts Bone Density in Women Receiving A...  [5/2008]
New ESA Restrictions Raise Concerns Over Impact on...  [4/2008]
Two New Studies Trigger More Warnings on Anemia Dr...  [3/2008]
more 

MAY, 2008
FREE PRINT SUBSCRIPTION
 
 
 
 
home  |  about us  |  advertise  |  contact  |  publications
 


Copyright ?2005 - 2008 McMahon Publishing unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.